Literature DB >> 11197527

Cytokine/neurotrophin interaction in the aged central nervous system.

N J Macdonald1, F Decorti, T C Pappas, G Taglialatela.   

Abstract

Age-associated neurodegenerative diseases such as Alzheimer's disease are characterised by neuronal impairment that leads to cognitive deficits. As certain affected neurons depend on trophic factors such as neurotrophins (NTs), impairment in NT function has been suggested to be a component of neuronal damage associated with such disorders. Age-related neurodegenerative diseases are also characterised by high levels of proinflammatory cytokines such as tumour necrosis factor alpha (TNFalpha) in the CNS. Because TNFalpha receptors and certain NT receptors share a high degree of homology and are capable of activating similar signalling pathways, one possibility is that altered cytokine levels may affect NT function in the aged or diseased CNS. Here we wish briefly to review the evidence suggesting a role for cytokine and NT in the onset of age-associated neurodegenerative diseases. We propose that cytokine/NT interactions may alter neuronal homeostasis, thus possibly contributing to some of the neuronal degeneration occurring during such age-associated CNS diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11197527      PMCID: PMC1468169          DOI: 10.1046/j.1469-7580.2000.19740543.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  100 in total

Review 1.  Biomarkers of Alzheimer disease.

Authors:  J H Growdon
Journal:  Arch Neurol       Date:  1999-03

2.  NSAIDs and incident Alzheimer's disease. The Rotterdam Study.

Authors:  B A in 't Veld; L J Launer; A W Hoes; A Ott; A Hofman; M M Breteler; B H Stricker
Journal:  Neurobiol Aging       Date:  1998 Nov-Dec       Impact factor: 4.673

3.  Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family.

Authors:  A Hohn; J Leibrock; K Bailey; Y A Barde
Journal:  Nature       Date:  1990-03-22       Impact factor: 49.962

4.  Molecular cloning and expression of brain-derived neurotrophic factor.

Authors:  J Leibrock; F Lottspeich; A Hohn; M Hofer; B Hengerer; P Masiakowski; H Thoenen; Y A Barde
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

Review 5.  The mode of action of nerve growth factor in PC12 cells.

Authors:  A Levi; S Biocca; A Cattaneo; P Calissano
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

Review 6.  p75NTR: A study in contrasts.

Authors:  P A Barker
Journal:  Cell Death Differ       Date:  1998-05       Impact factor: 15.828

7.  Nerve growth factor inhibits apoptosis induced by tumor necrosis factor in PC12 cells.

Authors:  R Haviv; R Stein
Journal:  J Neurosci Res       Date:  1999-02-01       Impact factor: 4.164

8.  Atypical PKC zeta is activated by ceramide, resulting in coactivation of NF-kappaB/JNK kinase and cell survival.

Authors:  Y M Wang; M L Seibenhener; M L Vandenplas; M W Wooten
Journal:  J Neurosci Res       Date:  1999-02-01       Impact factor: 4.164

Review 9.  Nerve growth factor and the basal forebrain cholinergic system: a link in the etiopathology of neurodegenerative dementias?

Authors:  E K Perry
Journal:  Alzheimer Dis Assoc Disord       Date:  1990       Impact factor: 2.703

Review 10.  A new concept in neurodegeneration: TNFalpha is a silencer of survival signals.

Authors:  H D Venters; R Dantzer; K W Kelley
Journal:  Trends Neurosci       Date:  2000-04       Impact factor: 13.837

View more
  2 in total

1.  Nerve growth factor (NGF) and lenses: effects of NGF in an in vitro rat model of cataract.

Authors:  Emiliano Ghinelli; Luigi Aloe; Magdalena Cortes; Alessandra Micera; Alessandro Lambiase; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-09-09       Impact factor: 3.117

2.  Inhibition of soluble tumor necrosis factor ameliorates synaptic alterations and Ca2+ dysregulation in aged rats.

Authors:  Diana M Sama; Hafiz Mohmmad Abdul; Jennifer L Furman; Irina A Artiushin; David E Szymkowski; Stephen W Scheff; Christopher M Norris
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.